Retour sur lavenir.net
   AEDIFICA 69.250 € (+0,14 %)     ARGENX SE 796.800 € (-0,38 %)     D'IETEREN GROUP 170.800 € (+0,06 %)     AB INBEV 69.200 € (-0,75 %)     LOTUS BAKERIES 11 320.000 € (+0,71 %)     EXMAR 11.300 € (+1,35 %)     VASTNED 29.250 € (-0,34 %)     SHURGARD 26.250 € (+0,96 %)     VGP 81.700 € (-0,12 %)     ELIA GROUP 135.400 € (-0,66 %)     GIMV 44.750 € (+0,22 %)     RECTICEL 11.200 € (+1,45 %)     BREDERODE 104.400 € (+0,77 %)     TITAN S.A. 50.100 € (+1,29 %)     IBA 16.720 € (+1,33 %)     ACKERMANS V.HAAREN 269.400 € (+1,05 %)     KBC 119.450 € (+1,44 %)     CENERGY 21.920 € (-0,27 %)     IMMOBEL 22.200 € (+0,91 %)     CARE PROPERTY INV. 12.640 € (+0,96 %)     ACCENTIS 0.027 € (+1,92 %)     TESSENDERLO 19.900 € (+0,51 %)     SOLVAC NOM(RETAIL) 73.500 € (0,00 %)     SIPEF 90.000 € (-0,22 %)     BEKAERT 39.650 € (+0,51 %)     SYENSQO 65.600 € (+1,31 %)     CELYAD ONCOLOGY 0.232 € (-0,43 %)     ONTEX GROUP 2.205 € (-4,13 %)     TINC 11.300 € (+1,07 %)     EVS 27.000 € (+1,12 %)     BIOTALYS 3.025 € (-0,33 %)     ENERGYVISION 14.820 € (0,00 %)     NYXOAH 1.502 € (-0,40 %)     XIOR 27.400 € (+1,11 %)     HOME INVEST BE. 19.020 € (+0,42 %)     KINEPOLIS GROUP 35.850 € (+0,56 %)     ASCENCIO 51.700 € (0,00 %)     FLUXYS BELGIUM D 19.500 € (0,00 %)     ECONOCOM GROUP 1.410 € (-1,40 %)     ORANGE BELGIUM 21.500 € (0,00 %)     MONTEA 66.800 € (+1,21 %)     JENSEN-GROUP 81.600 € (-0,73 %)     AGEAS 71.000 € (+0,14 %)     GBL 78.100 € (0,00 %)     VAN DE VELDE 30.000 € (+0,33 %)     WERELDHAVE BELGIUM 52.800 € (0,00 %)     WDP 21.820 € (+0,37 %)     SOLVAY 26.100 € (+0,77 %)     BPOST 1.608 € (+0,50 %)     MELEXIS 77.850 € (+5,20 %)     DEME GROUP 169.000 € (+0,60 %)     AZELIS GROUP 9.900 € (-0,50 %)     VIOHALCO 17.660 € (-1,45 %)     RETAIL ESTATES 68.400 € (+0,59 %)     ONWARD MEDICAL 2.500 € (+2,25 %)     AGFA-GEVAERT 0.420 € (+0,60 %)     CMB.TECH 13.000 € (-4,55 %)     FAGRON 23.950 € (+0,63 %)     KBC ANCORA 83.500 € (+2,08 %)     SOFINA 226.000 € (+0,71 %)  
   ASML HOLDING 1 602.800 € (+4,83 %)     KPN KON 4.226 € (-1,12 %)     CREDIT AGRICOLE 17.425 € (+1,31 %)     STELLANTIS NV 4.671 € (-0,48 %)     ENGIE 27.100 € (+1,19 %)     RELX 27.920 € (-0,78 %)     AXA 44.300 € (+0,66 %)     SIRIUS MEDIA 0.746 € (+11,00 %)     METAVISIO 0.001 € (+27,27 %)     WORLDLINE 9.929 € (-1,24 %)     WOLTERS KLUWER 59.920 € (+1,52 %)     POSTNL 0.932 € (+1,86 %)     EIFFAGE 121.100 € (+1,72 %)     ARCELORMITTAL SA 54.520 € (+1,72 %)     BE SEMICONDUCTOR 254.800 € (+5,59 %)     NEXITY 7.575 € (+0,13 %)     SCOR SE 31.560 € (-0,88 %)     PLANISWARE 20.500 € (+0,24 %)     BOOSTHEAT 0.500 € (-12,28 %)     SOITEC 104.100 € (+5,86 %)     ASM INTERNATIONAL 926.800 € (+4,16 %)     BIOMERIEUX 71.650 € (+3,62 %)     ADYEN 834.500 € (+0,53 %)     LAKEFRONT BIOTHER. 26.640 € (-0,60 %)     CAPGEMINI 89.000 € (-2,09 %)     DASSAULT SYSTEMES 18.210 € (+1,36 %)     VIRBAC 317.000 € (-1,86 %)     ABN AMRO BANK N.V. 38.250 € (+1,14 %)     AIRWELL 1.580 € (+3,27 %)     VALEO 12.460 € (+2,30 %)     PASSAT 4.880 € (0,00 %)     INPOST 15.420 € (+0,06 %)     PLUXEE 12.620 € (+2,52 %)     SAINT GOBAIN 74.320 € (-0,91 %)     LOGIC INSTRUMENT 2.080 € (+6,12 %)     FORVIA 9.002 € (+2,76 %)     PERNOD RICARD 63.600 € (-0,87 %)     AIRBUS 196.520 € (-0,43 %)     ESSILORLUXOTTICA 171.650 € (+1,36 %)     EXOR NV 67.600 € (-0,29 %)     SCHNEIDER ELECTRIC 270.000 € (+2,35 %)     AYVENS 11.790 € (+0,60 %)     SOCIETE GENERALE 73.210 € (+2,68 %)     SHELL PLC 35.740 € (-1,13 %)     ACCOR 48.660 € (+0,98 %)     TOTALENERGIES 68.820 € (-0,76 %)     EDENRED 23.550 € (+1,99 %)     CAPITAL B 0.454 € (+2,27 %)     ARCHOS 0.241 € (+5,47 %)     GOLD BY GOLD 4.710 € (+8,53 %)     BNP PARIBAS ACT.A 99.820 € (+1,58 %)     DSM FIRMENICH AG 84.000 € (+0,84 %)     VERIMATRIX 0.196 € (-0,76 %)     FERRARI GROUP 7.720 € (-0,26 %)     AKZO NOBEL 57.100 € (-0,42 %)     VINCI 119.350 € (+0,93 %)     GECINA 69.750 € (+0,72 %)     MAGNUM 15.926 € (-1,84 %)     PUBLICIS GROUPE SA 85.640 € (+0,56 %)     TELEPERFORMANCE 50.260 € (-0,83 %)  
News Réglementées
13/04/2023 13:43

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

The Vanguard Group, Inc. ( IRSH)
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

13-Apr-2023 / 12:43 GMT/BST


Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

  1.         Full name of discloser

The Vanguard Group, Inc.

  1.         Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

  1.         Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Horizon Therapeutics plc

  1.         If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

 

  1.         Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

11 April 2023

  1.           In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security
(Note 3)

US$0.0001 ordinary shares

 

Interests

Short positions

Number

%

Number

%

  1. Relevant securities owned and/or controlled

21,576,850

9.43%

 

 

  1. Cash-settled derivatives

 

 

 

 

  1. Stock-settled derivatives (including options) and agreements to purchase/ sell

 

 

 

 

Total

21,576,850

9.43%

 

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit
(Note 5)

US$0.0001 ordinary shares

Purchase

3,116

109.53 USD

US$0.0001 ordinary shares

Purchase

1,117

109.61 USD

US$0.0001 ordinary shares

Sale

976

109.53 USD

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per
unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/
received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

  

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 Not Applicable

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 none

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière